Senolytics Improve Bone Forming Potential of Bone Marrow Mesenchymal Stem Cells from Aged Mice

By using a calvarial defect model, scientists showed that a senolytic cocktail (dasatinib+quercetin; D + Q) improved osteogenic capacity of aged bone marrow MSC both in vitro and in vivo.